CHICAGO--(BUSINESS WIRE)--CytoCore (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, will hold its annual shareholders meeting on Thursday, June 21 in San Francisco. The meeting starts at 10 a.m. PDT and will be held at the Hyatt Regency San Francisco at 5 Embarcadero Center. Dr. George Gorodeski, Chief Scientist and head of CytoCore’s Medical Advisory board, will give a presentation on the state of CytoCore’s technology.
